Hyperkinetic movements are unwanted or excess movements that are frequently seen in
children with neurologic disorders. They are an important clinical finding with significant …

Botulinum toxin type A (BTX-A) is increasingly being used for the treatment of childhood
spasticity, particularly cerebral palsy. However, until very recently, all such use in this indication …

Introduction Head and neck cancer appears to be increasing in incidence, with potential
changes in aetiology proposed. This paper aims to provide a narrative overview of the …

Cerebral palsy (CP) is characterized by aberrant control of movement or posture and appears
early in life secondary to central nervous system damage. The symptoms of CP fallinto four …

Increased lipid peroxidation and reduced antioxidant status may contribute to the development
of complications in diabetes. The aim of this study was to assess the effects of dietary …

The independent effects of smoking and alcohol in head and neck cancer are not clear,
given the strong association between these risk factors. Their apparent synergistic effect …

It is now generally accepted that SARS-CoV-2 can be spread by aerosols as well as larger
droplets from the upper respiratory tract, although the relative importance of aerosol …

BACKGROUND: Although botulinum toxin is a well-established treatment of focal spasticity
in cerebral palsy, most trials have been small, and few have simultaneously assessed …

Management of hypertonia in cerebral palsy targets the functional goals of the patient and
caregiver. Treatment options are conceptualized as surgical or nonsurgical, focal or …

Spasticity from an upper motor neuron syndrome may cause a variety of symptoms that
interfere with function. Decisions regarding spasticity treatment are influenced by the chronicity, …